Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were developed as insulinotropic and anti-hyperglycemic agents for the treatment of type 2 diabetes, but their neurotrophic and neuroprotective activities have been receiving increasing attention. Myelin plays a key role in the functional maintena...

Descripción completa

Detalles Bibliográficos
Autores principales: Sango, Kazunori, Takaku, Shizuka, Tsukamoto, Masami, Niimi, Naoko, Yako, Hideji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298969/
https://www.ncbi.nlm.nih.gov/pubmed/35874814
http://dx.doi.org/10.3389/fcell.2022.950623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298969/
https://www.ncbi.nlm.nih.gov/pubmed/35874814
http://dx.doi.org/10.3389/fcell.2022.950623

Ejemplares similares